Logo | Name | Σ | Employees | ||
---|---|---|---|---|---|
Debiopharm we develop for patients Bridging the gap between disruptive discovery products and real-world patient reach, we identify high-potential compounds for in-licensing, we conduct clinical development and then select large pharmaceutical commercialization partners for out-licensing to maximize patient access across the globe. Through this specialized business model, Debiopharm can focus on the development of prescription drugs that target unmet medical needs in oncology and bacterial infections. Debiopharm completed the development and has licensed out 2 compounds: - Triptorelin, the active substance of Decapeptyl®/Trelstar®/Pamorelin®/Triptodur® 1, 3 and 6-month formulation and Moapar®/Salcacyl® -Oxaliplatin, the active substance of the branded Eloxatin®/Elplat®/Dacotin®/Dacplat® If your university … Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology | 6 | 4 | 3 | 494 | |
FAES FARMA Cuidamos de la salud hoy para construir una sociedad más sana mañana Founded in 1933, Faes Farma is a Spanish pharmaceutical company with a wide international presence. The company conducts research, produces and markets pharmaceutical products and raw materials, exporting to numerous countries. With 1,766 employees and headquarters, manufacturing and R&D center in Leioa (Bizkaia), Faes Farma has offices in Madrid and Barcelona, and subsidiaries in Portugal (Laboratorios Vitoria), Italy (with a 51% stake), Mexico, Guatemala, Colombia, Chile, Peru, Ecuador and Nigeria. Faes Farma also has a division dedicated to Animal Nutrition and Health (FARM Faes), which includes companies such … Type: Large company | 3 | 2 | 0 | 1,171 | |
INFARMA - The Employers’ Union of Innovative Pharmaceutical Companies INFARMA represents 24 leading companies in the innovative pharmaceutical sector The Employers’ Union of Innovative Pharmaceutical Companies, INFARMA, represents 24 leading companies in the pharmaceutical sector operating in Poland that conduct research & development and produce innovative medicines. INFARMA is a member of EFPIA, the Employers of Poland, and the Polish Chamber of Commerce. Type: NGO, Think-tanks, Ed, & Culture Activities: deeptech | 3 | 0 | 3 | 17 | |
Celltrion Inc Celltrion is a leading biopharmaceutical company that specializes in research, development and manufacturing of innovative therapeutics. We are committed to delivering innovative and affordable medications to promote patients’ access to advanced therapies. We have been at the forefront of biotherapeutic development uncovering new ways of targeting the drivers of disease by creating next-generation biologics and small molecule products. For additional information on our guidelines, please visit: http://tinyurl.com/bdh9bxs9 To transform possibility into a reality by promoting the health and welfare of mankind. We thrive to meet the needs of people who previously had limited access to advanced therapeutics. Type: SMB Activities: deeptech healthtech Technologies: Synthetic Biology | 1 | 0 | 0 | 1,521 | |
Medical Affairs Professional Society (MAPS) FOR Medical Affairs Professionals. BY Medical Affairs Professionals. 11,500+ members globally. Join the movement! MAPS is an active, global community of Medical Affairs professionals across a spectrum of fields, experience, and locales. With members like you, MAPS is transforming the Medical Affairs industry to increase its value to companies and, ultimately, benefit patients and consumers. Networking, Certifications, Medical Affairs Resources, Medical Affairs Career Center, Conferences, Meetings, Speaking, Information, and Webinars Type: Media | 0 | 0 | 0 | 68 | |
Advarra Advancing clinical research: safer, smarter, faster Advarra advances the way clinical research is conducted: bringing life sciences companies, CROs, research sites, investigators, and academia together at the intersection of safety, technology, and collaboration. With trusted IRB and IBC review solutions, innovative technologies, experienced consultants, and deep-seated connections across the industry, Advarra provides integrated solutions that safeguard trial participants, empower clinical sites, ensure compliance, and optimize research performance. Advarra is advancing clinical trials to make them safer, smarter, and faster. For more information, visit advarra.com. Central IRB, Human Subject Protection, IRB Services, Clinical Research, Independent IRB, Institutional Review Board, Ethics Review, … Type: Large company Activities: deeptech | 5 | 0 | 5 | 1,442 | |
Otsuka Pharmaceutical Companies (U.S.) Creating new products for better health worldwide. There are two Otsuka pharmaceutical industry companies in the U.S.: Otsuka America Pharmaceutical, Inc. (OAPI) successfully commercializes Otsuka-discovered and in-licensed products in North America. Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC) clinically develops and registers innovative healthcare products on a global basis. Neuroscience Type: Large company | 9 | 1 | 4 | 3,441 | |
Hikma Pharmaceuticals At Hikma, we help put better health, within reach, every day. For 45 years, we’ve been creating high-quality medicines and making them accessible to the people who need them. We are a trusted, reliable partner and dependable source of over 760* high-quality generic, speciality and branded pharmaceutical products that hospitals, physicians and pharmacists need to treat their patients across North America, MENA and Europe. We have 29 manufacturing plants, 8 R&D centres and c9,100 employees worldwide. *As of February 2024 Subscribe to our channel on YouTube https://youtube.com/@hikmapharmaceuticals5668 For all product information and enquiries, please contact us at PV@hikma.com Oral Generics, … Type: Large company | 0 | 0 | 0 | 8,432 | |
Laurus Labs Limited Knowledge . Innovation . Excellence Laurus labs is an innovation-driven ̧ people-centric & client-focused organization offering a broad and integrated portfolio of products & services to the global pharmaceutical industry. Equipped with a world-class infrastructure manned by best-in-class personnel & driven by the core values of knowledge, innovation and excellence, within a relatively short period, Laurus labs emerged as a segment-leading manufacturer of high quality APIs, a preferred partner for NCE development & manufacture & a trusted source of specialty ingredients for the nutraceutical industry. Given the strengths, capabilities & experience, Laurus Labs is uniquely positioned to help its clients … Type: Large company | 0 | 0 | 0 | 2,808 | |
LES PHARMACIENS ASSOCIES [Automatic translation follows] Together, let’s increase our chances of success! The Les Pharmaciens Associés network has developed a complete program to develop the pharmacist's pharmacy. Becoming stronger collectively to be stronger individually, this is the philosophy of our network, Les Pharmaciens Associés. Type: SMB Activities: entertainment | 4 | 0 | 4 | 16 | |
Regenosine Harnessing the healing potential of adenosine for tissue regeneration Privately held company focused on developing and marketing first-in-class regenerative therapies for osteoarthritis. Our proprietary platform technology harnesses the healing potential of the purinergic system which plays a critical role in maintaining cartilage homeostasis. Our lead product is a proprietary formulation for regenerating cartilage in joints with established osteoarthritis, targeting a rapidly growing joint preservation market. Our goal is to offer patients a disease modifying therapy with uncompromising efficacy relative to existing technologies. By developing this disease modifying therapy, we will significantly improve clinical outcomes and patient quality of life, and … Type: Startup Activities: biotech deeptech healthtech Technologies: Synthetic Biology | 0 | 0 | 0 | 2 | |
PharmagoraPlus [Automatic translation follows] The national pharmacy exhibition in France | See you on March 8 and 9, 2025 in Paris, Porte de Versailles Creation of new services, digitalization for overall patient care, improvement of the customer experience, reorganization of your pharmacy, increasingly connected patients... There are many changes you must face. To continue to exist tomorrow, your pharmacy must reinvent itself, redesign its businesses and adapt its economic model in order to find new growth levers. Just like your profession, as a national salon, we must also reinvent ourselves. This is why we have dedicated ourselves to all these challenges … Type: Startup Activities: healthtech | 8 | 2 | 3 | 1 | |
Gennisium Pharma Neonatology / Suitable Solutions for Preterm Infants Gennisium Pharma is a young French pharmaceutical company, which intends to develop, register and commercialize medicines dedicated to premature newborns and niche markets. Gennisium is looking for providing health care practitioners and neonatal intensive care units with novel and suitable formulations of medicines needed to prevent or treat neonatal diseases and conditions. Our company’s project aims to provide patients with medicines based on affordable prices and with global reach, regardless where the infants are born, whether in privileged or underprivileged countries. Feel free to contact us on info@gennisium.com Neonatology Type: Startup Activities: healthtech manufacturing | 1 | 1 | 0 | 10 | |
Care Factory [Automatic translation follows] Care Factory is a new, fast-growing consultancy firm. We work with our clients (industrialists, public and private payers, healthcare establishments) on issues of innovation, market access, optimization of care pathways and patient support. Health, Care pathway, Patient programs, Market Access, Medical-economic studies, and Strategic partnerships Type: Startup Activities: healthtech biotech deeptech | 0 | 0 | 0 | 3 | |
eVeDrug [Automatic translation follows] eVeDrug calls on different stakeholders all linked to the field of Pharmacovigilance: professionals from the pharmaceutical industry and scientists who have pooled their know-how, and with their experience acquired both from industrial environments (laboratories and manufacturers ) as well as Institutional environments (health authorities in different countries). eVeDrug wishes above all to restore trust between patients and their health system by placing the main interested party (the patient themselves) at the center of the health system responsible for protecting them. Thus, eVeDrug distributes the free My eReport application which allows any person (patient, relative, health professional, etc.) … Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 12 | 2 | 5 | 6 | |
PhysioStim Nonclinical expert in cardiovascular pharmacology & electrophysiology and vascular functions PhysioStim is a French preclinical CRO dedicated to cardiovascular pharmacology and electrophysiology from discovery stages to clinical development. Whatever the therapeutic areas, we ensure robust and valuable preclinical data on cardiac and vascular activities and secondary pharmacology to secure in-vivo development and bring new safe therapies to patients. Thanks to our predictive and translational models, we define the POC of drug discovery, we investigate secondary pharmacology with on and off-target liabilities, and we address the safety purpose to build and support your IND submission (with mandatory and not mandatory assays). … Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology | 0 | 0 | 0 | 10 | |
NovAliX NovAliX is a preclinical drug discovery-focused CRO NovAliX is a fully integrated drug discovery CRO supporting therapeutic programs from target identification to the delivery of preclinical candidates. NovAliX enables successful discovery programs through an award-winning team of medicinal chemistry and pharmacology scientists, and a variety of screening and characterization technologies, including an outstanding DNA-encoded library platform and a comprehensive portfolio of biophysical techniques, including an in-house cryo-EM facility. NovAliX’s presence in therapeutic areas now spans oncology, inflammation, fibrosis, and infectious and kidney diseases. For additional information, please visit www.novalix.com Target based drug discovery, NMR, SPR, Epigenetic targets, Nuclear receptors, Protein-ligand … Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology | 27 | 4 | 25 | 379 | |
Provepharm Act to improve life An independent, international specialty pharmaceutical company, Provepharm leverages the potential of mature and well-known molecules to develop innovative solutions that improve patients' lives. Provepharm develops, manufactures, and markets a range of hospital products including antidotes and dyes. Notably, the company is recognized for its expertise in the endoscopic and surgical dye markets. Working closely with healthcare professionals, Provepharm is committed to developing specific services aimed at helping them enhance clinical practices. With a team of over 160 professionals and offices in France, the US and UK, the company markets its products in over 25 countries worldwide … Type: SMB Activities: biotech deeptech manufacturing Technologies: Synthetic Biology | 5 | 4 | 2 | 149 | |
Genoscience Pharma Innovating to Disrupt Cancer Treatment Genoscience Pharma is a French biotech company developing unique small molecules in Oncology. This is the first clinical stage company ever with unique lysosomotropic agents assessed in global clinical trials. For more information, please visit our website, or call us +33 4 91 26 99 50. Liver, Oncology, Clinical Development, Preclinical Development, Discovery, Research & Development, Intellectual Property, Drug Development, and Small Molecule Type: SMB Activities: biotech deeptech manufacturing Technologies: Synthetic Biology | 6 | 2 | 4 | 8 | |
Keyrus Life Science The C2RO that helps connect Industry Expertise, Life Data Sciences and Digital Enablement. Keyrus Life Science is a Connected Contract Research Organization (C2RO), active for almost 25 years internationally, and part of the Keyrus group, an expert in data and digital solutions. Combining in-depth scientific and industry expertise, a deep understanding of life data sciences, and the integration of cutting-edge digital technologies, Keyrus Life Science optimizes the conduct of clinical trials and RWE projects, bringing greater agility and reliability, increasing their resilience and performance, and accelerating their execution. Keyrus Life Science supports life science industrials, such as the Pharmaceutical, Biotech … Type: SMB Activities: biotech deeptech healthtech Technologies: Data Analytics | 2 | 2 | 1 | 211 | |
Nicox Maintain vision and improve ocular health Nicox is an international ophthalmic R&D company, aiming to build a diversified portfolio of therapeutic products addressing the needs of eyecare practitioners and patients around the world. Our global growth strategy is focused on outstanding international collaborations and on our proprietary programs including those from our nitric oxide-donating research platform. For more information please visit www.nicox.com Pharmaceuticals, Ophthalmology, and Research and Development Type: SMB Activities: healthtech manufacturing Technologies: Synthetic Biology | 1 | 1 | 0 | 58 | |
Alira Health Where Empathy Meets Science to Accelerate Life Sciences Research Alira Health is a global healthcare firm whose mission is to humanize healthcare and life sciences in partnership with patients. From development to medical care, we complement the expertise of our Pharma, Biotech, and MedTech clients with a full spectrum of services across their entire solutions lifecycle, including clinical operations, real-world evidence, and patient-centric technology offerings. Our integrated and multidisciplinary team of over 800 scientists, strategists, economists, clinicians, and biostatisticians collaborate across our North American, European, and Asian offices and advise 80% of the top 50 MedTech companies and 75% of … Type: SMB Activities: biotech Consulting deeptech healthtech Technologies: Data Analytics | 8 | 1 | 2 | 619 | |
National Pharmaceutical Council Health policy research on value, evidence, innovation & access for patients. The National Pharmaceutical Council is a health policy research organization dedicated to the advancement of good evidence and science, and to fostering an environment in the United States that supports medical innovation. NPC's research helps to inform many critical health care policy debates and supports the organization's overall goal of achieving the best patient outcomes in the most efficient way possible. Over the years, the issues we have focused on have evolved along with the changes in the health care environment and pharmaceutical industry. NPC’s current research examines the … | 9 | 0 | 9 | 24 | |
PT Kalbe Farma, Tbk The Scientific Pursuit of Health for a Better Life Established in 1966, PT Kalbe Farma Tbk. (“the Company” or “Kalbe”) has gone a long way from its humble beginnings as a garage-operated pharmaceutical business in North Jakarta. It has expanded by strategic acquisitions of pharmaceutical companies, building a leading brand positioning and reaching to international markets to transform itself into an integrated consumer health and nutrition enterprise to promote its mission to improve health for a better life. Kalbe expands its business interests and transformed itself to become a provider of an integrated healthcare solution through its 4 business divisions: … Type: Large company | 0 | 0 | 0 | 8,151 | |
Hemofarm A.D. [Automatic translation follows] For more than 60 years, we wish you - every good - because we know that good health is our greatest wealth. Our history begins back in 1960 in the northeastern part of Serbia. Six decades were enough for us to develop from a small Vrsa plant to a company operating on three continents. Today, we are part of the global STADA family, which we joined in 2006. Together with the parent company, we build our overall approach to business as well as our corporate identity on four key values: Agility, Entrepreneurship, Integrity and One STADA. The … Type: Incubators & VCs | 3 | 0 | 0 | 1,380 | |
Chiesi France [Automatic translation follows] Taking care of patients and the planet today for tomorrow! CHIESI is an Italian family biopharmaceutical group offering innovative therapeutic solutions to patients in 3 therapeutic areas: AIR (products and solutions for respiratory diseases from newborns to adults), RARE (treatments for rare and ultra-rare diseases) , CARE (products and services in kidney and liver transplantation and prevention, in micronutrition) Bringing together nearly 6,500 employees worldwide, CHIESI is present in France across the entire value added chain – R&D, production, distribution and provision to healthcare professionals and patients – with a figure of business reaching nearly €175 million … Type: SMB Activities: healthtech deeptech Technologies: Synthetic Biology | 7 | 3 | 4 | 316 | |
Hamlet BioPharma An innovative pharmaceutical company with a broad portfolio of projects for the treatment of cancer and infections Hamlet BioPharma AB is a pharmaceutical company with strong links to research, working with natural and biological substances. The company was formed through the merger of two pharmaceutical companies, Hamlet Pharma AB and SelectImmune Pharma AB, and is listed on the Spotlight Stock Market. Hamlet BioPharma is a formidable pharmaceutical company specializing in the development of drugs for the treatment of cancer and infectious diseases. The company has a portfolio of a total of ten drug projects, three of which are in Phase … Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology | 0 | 0 | 0 | 8 | |
Cytovation Creating transformative medicines for patients with cancer Cytovation is a clinical stage immuno-oncology biotech developing first-in-class immunotherapies. CyPep-1, its lead asset, is a synthetic peptide engineered to selectively target tumor cells. CyPep-1 has a unique dual MoA applicable across solid tumors: (1) direct tumor-specific membrane lysis and in-situ vaccination, combined with (2) immune activation through inhibition of the β-catenin pathway. Building on strong FIH clinical data, Cytovation is advancing CyPep-1 to POC/pivotal clinical development with a focus on b-catenin-driven cancers. Biotech, Oncology, and Immuno-oncology Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 0 | 0 | 0 | 13 | |
Logichem Logichem is a pharmaceuticals company based out of 3 Wellesley Court, London, United Kingdom. | 1 | 1 | 1 | 9 | |
viomedo Even today many patients can’t effectively be treated with the standard of care. Most patients don’t want to wait many years until new therapies become available. They want to take action. They want to contribute to the medical progress. Viomedo connects patients with medical research in order to help improve existing therapies and find cures. We are the leading platform for medical research in the German speaking region. Together with researchers, patient support groups, research hospitals and pharmaceutical companies we want to transform medical research all over Europe. Viomedo - tomorrow’s medicine, today. Patient Recruitment, Clinical Trials, Internet, Innovative Treatments, … Type: Startup Activities: biotech deeptech Technologies: SaaS | 2 | 1 | 1 | 1 | |
Veracyte Biopharma Services Gain actionable insights to confidently advance every step of your oncology drug development programs. Veracyte is a global diagnostics company that empowers clinicians with the high-value insights they need to guide and assure patients at pivotal moments in the race to diagnose and treat cancer. We provide novel insights, expertise and capabilities that empower our biopharmaceutical partners to confidently advance every step of their oncology drug development programs. precision medicine, Biopharma, biomarker signatures, and Cancer care Type: Startup Activities: biotech deeptech Technologies: A.I. Data Analytics | 18 | 6 | 13 | 92 | |
Beta Innov [Automatic translation follows] Development of innovative drugs with curative potential in Immunology and Cancerology. Beta Innov SAS is an innovative pharmaceutical Research and Development company, created in March 2009 by patient families. Beta Innov aims to achieve a major therapeutic leap in the treatment of autoimmune diseases and Glioblastoma by using a physiological (Immunology) or metabolic (Glioblastoma) approach avoiding the costs of gene therapies and the adverse effects of therapies. by antibodies. Type: Startup Activities: biotech deeptech manufacturing Technologies: Synthetic Biology | 0 | 0 | 0 | 14 | |
Teva Santé [Automatic translation follows] Who is Teva Health? Present in more than 60 countries, the leading producer of active ingredients for the pharmaceutical industry, Teva is one of the largest pharmaceutical laboratories in the world. Its range of medicines, generic or not, allows the treatment of more than 120 pathologies. In France, its medications concern one in 12 prescriptions. But Teva's involvement goes well beyond just medicine. Its action is part of commitments in favor of patients, doctors, pharmacists and caregivers. With regard to the latter, the laboratory is particularly committed to helping them identify themselves, understand and master their role, … Type: SMB Activities: healthtech manufacturing Technologies: Synthetic Biology | 12 | 1 | 9 | 259 | |
Chiesi Group International pharmaceutical Group certified B Corp. Chiesi is an international, research-focused biopharmaceuticals group that develops and markets innovative therapeutic solutions in respiratory health, rare diseases, and specialty care. The company’s mission is to improve people’s quality of life and act responsibly towards both the community and the environment. By changing its legal status to a Benefit Corporation in Italy, the US, and France, Chiesi’s commitment to create shared value for society as a whole is legally binding and central to company-wide decision-making. As a certified B Corp since 2019, we’re part of a global community of businesses that meet high … Type: Large company | 10 | 2 | 6 | 5,331 | |
Morningside Pharmaceuticals Ltd "Making quality healthcare an affordable and accessible reality throughout the world." *For all Medical Enquiries email: medicalenquiry@morningsidehealthcare.com or call +44 (0)116 478 0322* Morningside Pharmaceuticals is an award winning manufacturer, wholesaler and exporter of branded and generic medicines and healthcare products to the UK and international markets. Since inception in the early 1990s, Morningside has exported to more than 120 countries globally and has over 240 generic and branded licensed medicines in the UK and EU. In the UK, the company’s licensed medicines are distributed twice daily to NHS hospitals and pharmacies. Globally, Morningside is one of the UK’s leading … Type: SMB Activities: deeptech healthtech manufacturing Technologies: Synthetic Biology | 2 | 0 | 2 | 55 | |
DrugPatentWatch Pharmaceutical Drug Patent Intelligence Find Your Next Blockbuster - Your single platform for accurate, objective, and timely intelligence Global biopharmaceutical drug patent and generic entry business intelligence. DrugPatentWatch Supports Critical Business Decisions: >Payers: Formulary and pharmacy & therapeutics (P&T) Anticipate future budget requirements and proactively identify generic sources > Branded pharmaceutical manufacturers Assess past successes of patent challengers and elucidate research paths of competitors > Generic manufacturers Inform portfolio management decisions on future drug development > Buyers, wholesalers, and distributors Predict branded drug patent expiration, identify generic suppliers, and prevent overstock of branded drugs > API manufacturers Obtain formulation and manufacturing information; identify final … Type: SMB Activities: deeptech biotech legaltech Technologies: Data Analytics | 0 | 0 | 0 | 4 | |
Frontage Laboratories, Inc Advancing drug discovery and development through integrated laboratory, analytical, and clinical services Frontage Laboratories, Inc. is a CRO that provides integrated, science-driven, product development services throughout the drug discovery and development process to enable pharmaceutical and biotechnology companies to achieve their development goals. Comprehensive services include drug metabolism and pharmacokinetics, analytical testing and formulation development, preclinical and clinical trial material manufacturing, bioanalysis, preclinical safety and toxicology assessment and early phase clinical studies. Frontage has enabled many biotechnology companies and leading pharmaceutical companies of varying sizes to advance a myriad of molecules through development and file regulatory submissions in the United … Type: SMB Activities: biotech deeptech manufacturing Technologies: Synthetic Biology | 0 | 0 | 0 | 661 | |
SYNERLAB GROUP Let's reach success together! Groupe SYNERLAB is a pharmaceutical Contract Manufacturing and Development Organization (CDMO). With six plants in France and Spain, Groupe SYNERLAB offers contract development and manufacturing of medicinal products for human and veterinary use, diagnostic, medical devices and food supplements in various dosage forms: solid dosage forms, non sterile and sterile liquids. Historitically dedicated to contract services, the medium size of the companies of the Groupe SYNERLAB allows to meet customers' requirements with great flexibility and reactivity. The six entities are: Laboratoires BTT - Z.I. de Krafft - 67150 ERSTEIN - France: tablets, hard capsules, betalactams Laboratoires … Type: SMB Activities: healthtech manufacturing | 3 | 2 | 1 | 535 | |
EURAXI Conception et réalisation de vos projets d'Etudes Cliniques, Registres, Programmes d'Accès précoces, Home Nursing 🚀✨ Euraxi (CRO) is a project management specialist in the health sector, assisting clients with their projects since 1986. Our organisation and service offer have been perfectly tailored to meet the precise needs of our clients. We can take on all or part of your operations thanks to our multidisciplinary team. This team is organised into specialised units and is guided by the risk management and quality procedures inherent to the requirements of your projects. - Clinical Operations - Data Management, eTools & Statistics - Medical … Type: SMB Activities: healthtech Technologies: Synthetic Biology | 1 | 0 | 1 | 115 | |
Cenexi Creating innovative partnerships | CDMO Cenexi, a French Contract Development and Manufacturing Organization with its 1,500 employees and 200 million € of turnover, is experiencing a steady growth with its four manufacturing sites (Fontenay-sous-Bois, Osny and Hérouville-Saint-Clair in France, Braine-l'Alleud in Belgium) and one development center for New Product Introduction. Created in 2004, the Cenexi Group is positioned on the very active international market for medicinal products with a major therapeutic indication, drawing on its spirit of innovation and its extensive expertise, both in manufacturing and in product development The arrival of the new top management team induces a new … Type: Large company | 5 | 0 | 5 | 933 | |
Early Drug Development Group (E2DG) Boost your program in Oncology We offer professional support all along the drug development life cycle, from lead optimization to Phase I clinical trials in oncology. We optimize and accelerate your R&D programs, based on our drug positioning-oriented philosophy. Early Drug Development Group is focused on building partnerships and strategic alliances with academic research institutions, universities, governmental agencies, small size biotechnology partners and investment funds. COLLABORATION WITH US IMPROVES YOUR RESOURCES INVESTMENT AND STRENGTHENS YOUR EARLY DRUG DEVELOPMENT PROGRAM IN ONCOLOGY. YOUR KEY BENEFITS • Assistance on preclinical, pharmacological and CMC approaches, clinical studies design, regulatory strategies and trials implementation … Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology | 0 | 0 | 0 | 1 | |
Mayoly [Automatic translation follows] Taking care to heart Through its subsidiaries, Mayoly is a family-owned, independent, French pharmaceutical and dermatological laboratory with an international footprint. For more than a century, it has successfully been growing its business with a focus on Gastroenterology and Dermocosmetics. Our French industrial heritage relates to our values of Responsibility, Pragmatism and Caring. We strive passionately and tirelessly to provide patients and people with the best possible healthcare daily, and aim to establish ourselves as a leader in Consumer Healthcare over the coming decades Our know-how applies to several therapeutic areas, such as gastroenterology, rheumatology, ENT, general … Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology | 8 | 1 | 2 | 878 | |
Pileje [Automatic translation follows] For 30 years, PiLeJe has distributed health solutions aimed at sustainably improving the quality and healthy life expectancy of patients with functional disorders, risk factors or chronic diseases. Complementary to medications, the health solutions developed by PiLeJe are prescribed by health professionals on the basis of individualized advice. To sustainably improve patient health, PiLeJe has expertise in four areas: health through microbiota, micronutrition, phytotherapy and medical nutrition. Key Figures: 300 employees spread across 5 sites in France 318 product references available Present in 35 countries including 6 subsidiaries (Spain, Benelux, Italy, Switzerland, Germany and Sweden) Micronutrition, Individualized … Type: SMB Activities: healthtech biotech | 10 | 2 | 1 | 478 | |
Universal Medica Group Decoding health and innovating for the well-being of patients Universal Medica Group has been supporting the healthcare stakeholders for more than 20 years by delivering innovative personalised solutions and quality medical content to enhance patient well-being and safety. Universal Medica Group provides 5 areas of expertise: - COMPLIANCE: Universal Medica offers consulting, support, and digital solutions to healthcare stakeholders in the outsourcing of vigilance, medical information, and quality management activities. - TRAINING: Europharma meets the training needs of Healthcare professionals with turnkey and customized solutions. - HEALTHCARE DIGITAL MEDIA AGENCY: Cherry provides medical content and offer multichannel communications for … Type: SMB Activities: biotech healthtech deeptech edtech Technologies: SaaS | 0 | 0 | 0 | 106 | |
Medsii.com Medsii.com is a UK B2B HealthTech Delivering Regulatory-Grade Medicines Intelligence Faster. Medsii.com is the flagship product of PharmaSentinel, a UK B2B HealthTech Providing Targeted Medicines Intelligence for Pharmaceuticals, Biotechs, Clinicians and Industry Analysts. Our flagship app Medsii.com (also on the App Store & Play Store) leverages AI to offer more accurate and more efficient information management, giving our customers a competitive edge. Our solution is already being used by leading pharmaceutical companies. #Pharmaceuticals #Medicines #RegulatoryInformation #ClinicalInformation #DigitalSolutions HealthTech, Digital Health, Startup, and AI Type: Startup Activities: healthtech Technologies: A.I. | 6 | 0 | 6 | 1 | |
Ultimaxx Health Changing The World Naturally At Ultimaxx Health we have made it our mission to develop innovative solutions to pressing public health problems and Natural products that will improve the general health and well being of consumers. Our initial US Patented product is a safe, effective, clinically tested non-narcotic OTC pain relief alternative (tablet form), marketed under the trade name LEVARE® (la-var-ay). LEVARE was developed to help mitigate the epidemic of prescription narcotic "painkiller" abuse in the U.S. The U.S. comprises 5% of the world's population and consumes 80% of it's prescription narcotics. Because of this excessive consumption, the U.S. is … Type: Startup Activities: biotech deeptech manufacturing Technologies: Bio sourced materials | 1 | 1 | 1 | 6 | |
Agios Pharmaceuticals Where science meets heart. Passionately committed to transforming the lives of people with genetically defined diseases. Agios is a biopharmaceutical company that is fueled by connections. We are passionately committed to applying our leadership in the field of cellular metabolism to create life-changing therapies for people living with rare diseases. The bonds we build with patient communities, healthcare professionals, partners and colleagues help elevate our thinking and propel our science to new heights. These connections, combined with our cellular metabolism expertise, have fueled the development and approval of our first-in-class pyruvate kinase (PK) activator, as well as other investigational therapies. … Type: Startup Activities: biotech healthtech deeptech Technologies: Synthetic Biology | 2 | 1 | 1 | 505 | |
Virpax Pharmaceuticals Inc. (Nasdaq:VRPX) Collaborating with NIH & DoD to develop treatment options, targeting unmet needs in three multi-billion dollar markets. Virpax is pioneering advanced healthcare solutions with Probudur, its flagship product leveraging proprietary liposomal encapsulation. Designed for sustained release, Probudur delivers local anesthetic at the wound/incision site, effectively managing post-operative pain for an extended 96 hours. Collaborating through Cooperative Research and Development Agreements (CRADA) and partnering with prestigious institutions like the National Institute of Health/NCATS and U.S. Army Institute of Surgical Research/Department of Defense, we are committed to developing non-addictive treatments. Additionally, our involvement in the Epilepsy Therapy Screening Program (ETSP) underscores our … Type: Startup Activities: biotech deeptech healthtech manufacturing Technologies: Synthetic Biology | 0 | 0 | 0 | 14 | |
VALWIN [Automatic translation follows] supports pharmacists in their digital shift and their new missions, by creating their digital platform. 🎯 VALWIN supports pharmacists and groups in their digital transition by creating their digital platforms (website, mobile application, back office) to boost their activity and strengthen the bond with their patients! Our ambition ? Improve the coordination of health professionals around the patient and make the patient an actor in their health 🚀 Digital platforms for pharmacies, Digital platforms for groups, Connected services to connect pharmacists, patients and groups, Prescription reservation, Online sale of medicines and parapharmacy, Secure messaging, A team dedicated … Type: Startup Activities: healthtech Technologies: SaaS | 9 | 5 | 5 | 18 | |
Cilcare MAKING HEARING A PRIORITY CILCARE is a biotech dedicated to harnessing auditory sciences to reshape the future of care via early diagnosis and targeted treatment. We believe hearing acts as a valuable indicator of our health and must be monitored and preserved accordingly. As awareness of the link between hearing and chronic health conditions grows, auditory sciences are paving the way for the early detection of chronic neurocognitive, inflammatory, and age-related diseases. CILCARE External Innovation supports its partners in the health and life-sciences sector in the development of new therapies to prevent and treat auditory-related diseases including inherited hearing loss, … Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 29 | 9 | 25 | 33 | |
Spinleap We leverage the most advanced technologies to improve patients' life. Why Spinleap? The world is changing faster than ever. Technologies are disrupting business models at an accelerating pace. Healthcare is reaching a turning point. Spinleap is Ipsen’s answer to this new need for speed and agility. Our Missions *Acceleration: we accelerate high value internal projects by using technology. *Open Innovation: we partner with academics & tech startups to build win/win innovative products. *Disruption: we explore and test emerging technologies to create new ways to improve patients’ life. Contact us We are looking for experts on any relevant technology (IoT, AI, … Type: Startup Activities: deeptech biotech Technologies: Robotics IoT Blockchain/Cryptocurrency A.I. | 2 | 0 | 0 | 1 | |
Advicenne Pathbreaking treatment for rare diseases. Advicenne is a specialty pharmaceutical company dedicated to improving the lives of patients who suffer from rare renal diseases. Advicenne have spent more than 10 years developing products for the treatment of rare renal diseases. At Advicenne, we are committed to developing and commercializing medicines that are suitable for both children and adults – groundbreaking treatments for rare diseases should be available to patients of all ages. Laboratoire Pharmaceutique | 0 | 0 | 0 | 28 | |
Doklog [Automatic translation follows] Create your health communication platform Your health information network. Platform intended for all health stakeholders: professionals, patients, establishments, associations, authorities, manufacturers, etc.). health, social media, hcsmeufr, and startup Type: Media Startup Activities: healthtech biotech deeptech Technologies: SaaS | 1 | 0 | 0 | 0 | |
POLEPHARMA [Automatic translation follows] The French (bio)pharmaceutical industrial sector. Polepharma structures the French (bio)pharmaceutical industrial sector and has been supporting its transformation for 20 years. Polepharma has become the first pharmaceutical industrial cooperation in Europe, between areas of excellence and players in the sector: 400+ members, 60% of production & 70k jobs in France. Established in 5 territories (Centre-Val de Loire, Ile-de-France, Normandy, Occitanie, Nouvelle-Aquitaine), Polepharma supports its members throughout France. These are laboratories, suppliers, schools, collectives, experts, talents who want to make France the best place in the world to develop & produce medicines, that is to say cutting-edge, virtuous, … Type: NGO, Think-tanks, Ed, & Culture Activities: healthtech | 47 | 26 | 27 | 28 | |
OCP Répartition [Automatic translation follows] Leader & Reference for the Pharmacy of Tomorrow OCP at the heart of the health chain OCP is both the leader and the historical referent (1924) of pharmaceutical distribution in France. By providing pharmaceutical logistics and efficient services, OCP is the essential link between laboratories and pharmacists. Every day we contribute to better health. With a territorial network of 41 establishments in France, OCP holds nearly 32% market share and distributes 2 million boxes of medicines every day to 16,000 customer pharmacies (including 2,000 hospital pharmacies), from a range of 36,000 references available. OCP is the first … Type: Large company | 13 | 3 | 10 | 1,351 | |
Xeris Pharmaceuticals, Inc. We're a growth-oriented biopharmaceutical company improving patient lives by developing and commercializing advanced products across a range of therapies. | 2 | 0 | 1 | 372 | |
MSD Sverige [Automatic translation follows] Research and innovation for patients is our lifeblood. This is how we contribute to a strong life science arena in Sweden. MSD Sweden's official LinkedIn. About us: http://www.msd.se/om-oss/ Life at MSD http://www.workforlife.com/ Follow us on Twitter under the name @MSDSverige We are on Youtube under the name @Innovation Sweden Questions about MSD medicines: medicinskinfo@merck.com. Adverse event reporting: pv.sweden@merck.com. Complaints: mmd.pqc.hh.sweden.chu@merck.com. Oncology, Diabetes, Hospital Specialty Care, Cardiovascular, Vaccines, and Women's Health Type: SMB Activities: deeptech biotech Technologies: Synthetic Biology | 0 | 0 | 0 | 89 | |
NDA Group AB Let's bring medicines to the world, because the world is waiting NDA is a world-leading regulatory and drug development company, with 25 years of excellence, an extensive portfolio of services, and more than 1600 clients. Over the last three years, NDA Group has supported a quarter of the new medicinal products approved in the US and Europe. Our dedicated team of over 150 consultants combined with the unique NDA Advisory Board provide drug developers with unmatched regulatory expertise, ensuring the safe development of complex & innovative treatments that meet the rigorous requirements of the regulatory agencies. We are a genuine … Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology | 1 | 0 | 1 | 139 | |
Fresenius Kabi FR [Automatic translation follows] Fresenius Kabi is a global healthcare company specializing in life-saving medicines and medical devices in infusion, transfusion and clinical nutrition. Fresenius Kabi's medicines, technologies and services are used to help care for patients in emergency situations or with chronic illnesses. Fresenius Kabi's product portfolio includes a full range of generic intravenous medications, infusion therapies, clinical nutrition products as well as the medical devices required to administer these products. In the biosimilars space, we focus on autoimmune diseases and oncology. In 2019, Fresenius Kabi's first biosimilar product was launched. In the field of transfusion medicine and cell therapies, … Type: SMB Activities: biotech deeptech healthtech Technologies: Synthetic Biology | 8 | 1 | 7 | 448 | |
Texcell Expert in viral safety since 1987. Texcell is a dedicated partner for biotechnology and pharmaceutical companies since more than 2 decades. Thanks to an unique combination of expertise in Virology and Immunology, we can provide a full support to your product development from the proof of concept to clinical studies and GMP manufacturing. Our state-of the Art facilities are located in France, Germany and in the US where we use most recent technologies to efficiently perform a wide range of assays What do we provide ? A specialized analytical lab for your preclinical and clinical studies, including: - Cell based … Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology | 7 | 0 | 7 | 113 | |
Ophtalmic Compagnie [Automatic translation follows] Your partner for vision since 1986 A vision partner of the French since 1986, Ophtalmic Compagnie is an independent laboratory with nearly 170 employees. The company generates 45 million euros in turnover in the design and distribution of corrective and cosmetic contact lenses, lens care solutions, food supplements for visual health and also ophthalmic lenses. This is subdivided into 5 distinct areas of activity: -Ophthalmic Contactology (contactology products, lenses and solutions) -Ophthalmic Vision (corrective lenses and frames) -Ophtalmic Santé (micro nutrition products for eye health) -Ophthalmic Services (multi-brand distribution of contact lenses and care solutions) - Ophtalmic … | 1 | 0 | 1 | 105 | |
Medincell Better Medicine For All Better Medicine for All MedinCell is a pharmaceutical company at commercial stage. We develop a portfolio of long-acting injectables in various therapeutic areas. Our proprietary technology BEPO® aims to ensure patient compliance, improve the effectiveness and accessibility of treatments, and reduce their environmental footprint. We collaborate with tier-one pharmaceutical companies and foundations to improve Global Health through new therapeutic options. Our mission is to contribute to the improvement and protection of the health of populations across the world. The fair sharing of the value created with all our employees is the foundation of our business model. … Type: SMB Activities: biotech deeptech healthtech Technologies: Synthetic Biology | 4 | 1 | 2 | 146 | |
ABL GMP PURE-PLAY VIRAL VECTOR CDMO. From development to market ABL Europe provides GMP viral vectors, contributing to the success of our clients’ immunotherapy innovations. ABL Europe SAS is a pure-play GMP CMO licensed in accordance with EMA, completely dedicated to the provision of viral vector GMP contract manufacturing services, and a subsidiary of ABL Inc. under the corporate ownership of Institut Mérieux. ABL has a strong technical & regulatory track record in process development, scale-up & GMP manufacturing of filterable & non-sterile filterable (aseptic processing) viral vectors used in all phases of clinical development globally. With different adherent platforms (< … Type: SMB Activities: deeptech biotech Technologies: Synthetic Biology | 5 | 5 | 2 | 515 | |
Rondol Group We created Rondol Industrie in 2012 with the goal of adapting Hot Melt Extrusion (HME) technology to the micro scale and to pharma standards and contributing therefore to better and cheaper healthcare. We are now HQ'd in Nancy, France. Rondol is a privately owned Deeptech company which patented the All-in-One Vertical twin screw extruder, representing a significant innovation in pharmaceutical manufacturing due to its capacity to increase the efficiency of drug formulation and delivery, and allowing for more effective therapeutic solutions. What sets this technology apart is its ability to handle complex formulations, enhance drug solubility, and improve bioavailability. These … Type: Startup Activities: IT Services manufacturing Technologies: Synthetic Biology | 3 | 2 | 1 | 10 | |
Kricri Kricri, 100% French natural softness. Specialized in the treatment of skin and hair for the youngest ones, Kricri has entrusted the development of its formulas to Laboratories which have been recognized in the field of Dermo-Cosmetics for the past 160 years. Our commitment: a strict quality charter and solid manufacturing practices before anything. Only in this way can we guarantee the present and future compliance of all our products with very strict standards. Among which, the ISO 22716 (BPF), ISO 9001, Certification NOP (National Organic Product), Ecocert and Cosmos. beauté, cosmétiques, santé, soins pour la peau, and soins pour les … Type: Startup Activities: cosmetics healthtech manufacturing Technologies: Bio sourced materials | 0 | 0 | 0 | 3 | |
Odimma Therapeutics Empowering Personalized Immunotherapy to Treat Cancer Odimma is a French biotech company with a unique approach in active personalized cancer immunotherapy. Immunotherapy has revolutionized the treatment of many advanced cancers. Despite this amazing achievement, significant clinical benefits are still limited to 10 to 30% of patients. Odimma believes in the future of precision medicine, and leverages recent advances in the field of immuno-oncology to amplify the efficacy of current therapies, improving lives and making each patient unique. By harnessing the ability of the patient’s own immune system to specifically recognize non-self-targets displayed by the tumor, also called neoantigens, Odimma has … Type: Startup Activities: deeptech biotech manufacturing Technologies: Synthetic Biology | 10 | 3 | 8 | 7 | |
ZAWADI Specialist in Afro-mtissue skin Zawadi is the new 100% French cosmetic skincare brand that is going up, going up, going up and not about to stop! Zawadi is a love story dedicated to all children and especially to sun-skinned children. Type: Startup Activities: kidtech cosmetics healthtech | 1 | 1 | 0 | 8 | |
SYNSIGHT Drug discovery from inside the cell We aim to make Drug Discovery faster, cheaper and smarter ! Early-Stage Drug Discovery includes many Design-and-Test cycles. A large Pharma company may go through 25 cycles or more in a single year! This is where Synsight comes in: we help our clients and partners to make focused decisions on which molecules to make; how and why certain molecules exert a biological activity (or fail to); how to enhance the activity or selectivity of lead molecules, or make them more drug-like; and even how to find new indications for known drugs. criblage virtuel, modélisation … Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 10 | 1 | 8 | 10 | |
Domain Therapeutics #biopharma #biotech #drugdiscovery #GPCR #Immunooncology #immunosuppression Domain Therapeutics, a clinical-stage global biopharmaceutical company, focused on developing innovative immunotherapies targeting G Protein-Coupled Receptors (GPCRs), one of the most important drug target classes, to unlock new possibilities in cancer. As a leader in GPCRs in immuno-oncology, Domain sees cancer differently, using a precise biomarker strategy to address the specific needs of patients based on unique signatures of individual cancers. Two decades of solid experience in GPCR drug discovery, validated by multiple pharma partnerships, associated to a target identification and drug discovery platform enable the Company to enhance the understanding of cancer and … Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 13 | 5 | 9 | 94 | |
Valerio Therapeutics Valerio is a clinical-stage biotechnology company developing novel oncology drugs targeting tumor DNA-binding functions. Valerio Therapeutics is a clinical-stage biotechnology company based in France and the US that develops new drugs by targeting tumor DNA functions through unique mechanisms of action in the field of DNA Damage Response (DDR). DDR consists of a network of cellular pathways that detect, report and repair DNA damage. Applied to oncology, this new field of research aims to weaken or block the ability of tumor cells to repair damage to their DNA, either naturally or under the effect of cytotoxic treatments. Focusing exclusively on … Type: Startup Activities: biotech deeptech manufacturing Technologies: Synthetic Biology | 1 | 1 | 0 | 60 | |
Butterfly Therapeutics (Previously Lucine) The medical device to relieve your pelvic perineal pain. Lucine is part of Butterfly Therapeutics since december 2023. Lucine is an expert in women’s pelvic pain relief, and we’re on a mission to change women’s lives. We offer an evidence-based approach with scientifically proven solutions that reduce & relieve pain related to endometriosis, periods, menopause, post-partum discomfort, and more. Endocare is our clinically-tested, patented medical device that directly targets pain mechanisms with a unique combination of visual and sound frequencies Let's work together, changing women's lives ! Pain, Digital therapeutics, Data, AI, Neurosciences, Sociology, Addiction, Health, Hospital, and CBT Type: Startup Activities: deeptech healthtech manufacturing Technologies: A.I. | 37 | 15 | 26 | 23 | |
Centrient Pharmaceuticals Global B2B leader in sustainable, enzymatic antibiotics, next-generation statins and anti-fungals Centrient Pharmaceuticals is the global business-to-business leader in sustainable, enzymatic antibiotics, next generation statins and anti-fungals. We produce and sell intermediates and active pharmaceutical ingredients (APIs), as well as our own tablets, capsules and other finished dosage forms (FDFs). We stand proudly at the centre of modern healthcare, as a maker of essential and life-saving medicines. With our commitment to Quality, Reliability and Sustainability at the heart of everything we do, our over 1,800 employees work continuously to meet our customers’ needs. We work towards a sustainable future by … Type: SMB Activities: biotech deeptech manufacturing Technologies: Decarbonization | 3 | 1 | 2 | 858 | |
PharmaVie [Automatic translation follows] Our well-being. Your well-being. NETWORK OF INDEPENDENT PHARMACISTS UNDER BRAND Private Label Branded products ISOMED our branded generic range Commercial dynamism Brand marketing Price policy Training NUTRITHERAPY The sign is an important visual identification for the pharmacist who must now group together in view of the economic changes in the pharmacy (OTC, drop in margins, CAP, etc.) Pharmaceutical industry, Parapharmacy, and Pharmacy | 6 | 1 | 2 | 106 | |
BIOGARAN [Automatic translation follows] The box that takes care of you. French drug laboratory 🇫🇷 Biogaran was founded in 1996, to specifically respond to the development of a new, still little-known market: generic medicines. Offering patients quality medicines with recognized effectiveness whose patent has fallen into the public domain then required a new type of know-how that traditional laboratories did not possess. Our know-how is available through different ranges: from minor everyday ailments with the Biogaran Conseil® range, to more serious pathologies with prescription medications. Whatever the pathology, patient health is at the heart of Biogaran's concerns and the same rigor … Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology | 8 | 2 | 4 | 506 | |
Kayentis Simplify your clinical trial experience Kayentis, a global provider of eCOA (electronic Clinical Outcome Assessment) and Decentralized Clinical Trial solutions (DCTs), helps pharma, biotech and CROs bring simplicity, efficiency and quality to the collection of clinical trial data from both patients and sites. Since 2005, Kayentis has been active in clinical development, with a strong specialization in eCOA solutions for phases I-IV across a broad range of therapeutic areas. Over the years, it has developed a full range of services and has enlarged its portfolio beyond eCOA solutions to support the new normal of decentralized and hybrid trials. The company … Type: SMB Activities: biotech deeptech Technologies: Data Analytics | 6 | 5 | 2 | 166 | |
Laboratoires Théa Théa, Let's Open Our Eyes Laboratoires Théa is a pharmaceutical industry specialized in ophthalmology. The group is the leader in several therapeutic classes as well as in the field of preservative-free eye drops. Laboratoires Théa is an innovative company dedicated to developing high-quality products that support ophthalmic care and eye health across more than 70 countries. Ophthalmology, Pharmaceuticals, Medical Devices, Eye care, Eye Health, and Preservative-free Type: SMB Activities: healthtech biotech deeptech Technologies: Synthetic Biology | 8 | 6 | 2 | 755 | |
Qualicaps Engineered to perform Qualicaps® is a global manufacturer of empty pharmaceutical capsules and pharmaceutical processing equipment. With more than 100 years of experience, Qualicaps is a leader in innovation in both Quali-GTM (gelatin) and Quali-V® (hypromellose) capsules, and offers a proprietary product line of pharmaceutical equipment, including capsule filling, band-sealing and inspection machinery. For more information visit www.qualicaps.com. Capsules and Equipment Type: Startup Activities: Industry 4.0 manufacturing | 0 | 0 | 0 | 225 | |
PharmaExcipients.com PharmaExcipients.com is an unique information and exchange platform on major topics related to pharmaceutical excipients pharmaexcipients.com is the all-in-one platform for users, manufacturers and people sharing the interest of #excipients. The unique combination of information and sourcing with immediate access to products and suppliers. Like to hear more about the platform and the possbilities? Fix an appointment here: https://calendly.com/pharmaexcipients Pharmaceutical excipients, inactive ingredients, excipient sourcing, excipients, webinar, Video, digital marketing, B2B pharma marketing, and excipient samples | 0 | 0 | 0 | 4 | |
Curlew Research Enabling Life Science using data science, AI and informatics Curlew Research enables better Health & Life Science (H&LS) research through our expertise in informatics, data & strategy development including collaboration, externalisation, data sharing and integration across the complete workflow. We want to develop strong partnerships with organisation to help support their growth and success. We have key experience of working virtually in projects (IMI OpenPhacts, FAIRplus, Transmart Foundation) and in founding and growing organisations such as Pistoia Alliance. informatics, strategy, mhealth, consulting, market research, life science, lab informatics, ML/AI, FAIR data, data management, and drug discovery Type: Startup Activities: deeptech Technologies: Data Analytics | 0 | 0 | 0 | 3 | |
MSD Italia [Automatic translation follows] We have always invented for one great purpose: Life We have always invented for one great purpose: Life MSD, known in the United States and Canada as Merck & Co., Inc., with headquarters in Kenilworth, (New Jersey, USA), is an American multinational leader in the pharmaceutical sector. For over 65 years in Italy and 130 in the world, we have revolutionized therapeutic paradigms for dozens of pathologies through the discovery of over 200 innovative molecules. Our mission is to discover, develop and make available innovative products and services that save and improve the lives of Patients around … Type: Startup Activities: deeptech healthtech Technologies: Synthetic Biology | 10 | 0 | 5 | 505 | |
WCG We improve lives by accelerating research, together. WCG is a true partner to research sponsors, CROs, sites and participants in navigating the clinical research journey. The pioneer of independent ethical review, now the industry gold standard, WCG’s 55-year legacy of independent review solutions serves as the foundation on which we continually build to accelerate and improve the clinical research journey. We lead the way by reimagining processes, optimizing quality and safety, strengthening productivity, and pioneering new solutions that leverage data and technology to accelerate research and impact global health. WCG liberates study stakeholders from the constraints that risk trial efficacy … Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology | 1 | 0 | 1 | 1,243 | |
British Generic Manufacturers Association (BGMA) Better Access, Better Health The British Generic Manufacturers Association (BGMA) represents the interests of UK-based manufacturers and suppliers of generic medicines and promotes the development and understanding of the generic medicines industry in the United Kingdom. Generic medicines contain the same active ingredient and are as effective as their equivalent brands. Type: Startup Activities: healthtech | 4 | 0 | 4 | 11 | |
Pillar Healthcare Limited pre-Conceive is a clinically studied fertility supplement shown to improve the key fertility parameters in both sexes. Pillar Healthcare Ltd., is a Manx based company established to address the global decline in male and female fertility. Pillar through its founder, Mark Whitney, designed the nutritional aid, pre-Conceive. pre-Conceive is a nutritional formulation that is proposed as a conjunctive aid to assisted reproduction and a viable aid in improving key fertility parameters. In a landmark independent clinical study, a first of its kind, Pillar's unique formulation was examined. The conclusion stated "pre-Conceive combined with nutritional advice improves the levels of key … Type: Startup Activities: healthtech Technologies: New Materials | 0 | 0 | 0 | 2 | |
Civica Rx Serving patients is a privilege that comes with significant responsibilities. Civica Rx was created in late 2018 to secure the supply of important medicines hospitals use every day. As of Q1 2024, we have provided over 155 million units of essential medicines to hospitals, enough to help treat nearly 70 million patients. Recently, we announced we will manufacture and distribute affordable medications for consumers in an outpatient/retail setting, including affordable insulin. Insulin is an exciting project as we are partnering with nearly every corner of the diabetes ecosystem to bring low-cost insulin to people living with diabetes at no more … Type: Startup Activities: deeptech biotech manufacturing Technologies: Synthetic Biology | 1 | 0 | 0 | 160 | |
BOIRON España / BOIRON Spain BOIRON es una compañía farmacéutica familiar líder en la fabricación y distribución de medicamentos homeopáticos Boiron es un laboratorio farmacéutico familiar e independiente, especialista en la fabricación de medicamentos homeopáticos de gran calidad desde hace un siglo. Presente en más de 50 países, con 3900 colaboradores, desarrollamos con rigor y pasión nuestro compromiso con la salud Boiron is an independent, family-run pharmaceutical laboratory. With 3 700 employees and a presence in more than 50 countries, we have been specialising in the production of very high quality homeopathic medicines for a century. As the world leader in homeopathic medicines, we are … Type: Startup Activities: healthtech manufacturing Technologies: Bio sourced materials | 0 | 0 | 0 | 89 | |
ABC transfer Ultraclean Sterile Transfer Solutions For The Global Pharmaceutical Industry ABC Transfer is an industrial designer and manufacturer of secure Rapid Transfer Systems (RTS) for the pharmaceutical industry. It provides the ultimate sterile and particle-free environment for safe drug manufacturing and bioprocessing; ensuring GMP compliance, ultra-cleanliness and enhanced ergonomic safety. Its system consists of future-proof alpha doors, beta containers, single-use bags and other superior quality sterile processing accessories based on 12 patented designs. The ABC Transfer system is the first to satisfy 50 improvement criteria resolving customers’ challenges worldwide. Led by an executive team of pharma transfer solution experts with decades … Type: Startup Activities: Industry 4.0 manufacturing Technologies: Synthetic Biology | 0 | 0 | 0 | 11 | |
Vaxxel The future of vaccines against respiratory infections. Vaxxel develops novel and proprietary live-attenuated vaccines candidate against bronchiolitis and pneumonia and in particular against human Metnapneumovirus and against human Respiratory Virus. Vaxxel is a spin off fom Virpath, the virology and human pathology Laboratory of the University Claude Bernard in Lyon (UCBL), France, and has been founded by Dr. Manuel Rosa-Calatrava Co-Director of Virpath (Lyon), Pr. Guy Boivin of the University of Laval (Quebec), by Denis Cavert, President of Vaxxel. recherche-développement, biotechnologies, santé, and vaccin Type: Startup Activities: deeptech manufacturing Technologies: Synthetic Biology | 6 | 0 | 6 | 11 | |
ETISENSE Jacketed physiological monitoring for life sciences Etisense, is a Lyon (FR) based MedTech company specialized in non-invasive physiological monitoring. Etisense develops unique instrumentation solutions for pre-clinical research and development. DECRO, (www.etisense.com),our 1st product is now available to help scientists to perform pre-clinical research differently. recherche, R&D pharmaceutique, Instruments connectés, and Plateforme d'acquisition de signaux physiologiques Type: Startup Activities: biotech deeptech manufacturing | 3 | 1 | 2 | 12 | |
KCAS Bio - Lyon Science Accelerated KCAS Bio - Lyon (Active Biomarkers) operates as a bioanalytical laboratory based in Lyon, France and headquartered in Olathe, Kansas, USA. We offer comprehensive service solutions for the development of both large and small molecules, with extensive capabilities and expertise in pharmacokinetics, immunogenicity, soluble and cellular biomarker analysis for clinical trials. Operating in state-of-the-art BSL2 facilities, our company is GLP certified and ISO 9001:2015 certified, with a unique track-record in the development, validation, and implementation of analytical methods. Our expert team has supported hundreds of studies in multiple therapeutic areas: oncology, infectious diseases, inflammatory pathologies, and neurodegenerative diseases. … Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology Data Analytics | 2 | 1 | 2 | 30 | |
ORPHELIA Pharma Our mission is to develop essential medicines to improve care and support of pediatric orphan diseases ORPHELIA Pharma is a French pharmaceutical company dedicated to the development and marketing of pediatric drugs for oncology and CNS diseases. ORPHELIA’s mission is to significantly improve essential medicines administered to children through the development of efficient, reliable and safe drugs with child-friendly formulations. We focus on developing optimized formulations for the pediatric population of approved drugs as well as obtaining the approval for existing drugs in new pediatric orphan indications. We are also leading R&D projects aiming at developing new drugs for pediatric … Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 1 | 1 | 0 | 10 | |
Exeliom Biosciences Crossing the next frontier, to give you a fair chance to fight Exeliom Biosciences is a clinical-stage biotechnology company developing next-generation immunotherapies in immuno-oncology and immuno-inflammation. Our novel candidates harness microbiome-associated innate immune regulatory mechanisms. Inflammatory Bowel Diseases, Live Biotherapeutics, Microbiome, Immunotherapies, Immuno-oncology, and Immuno-inflammation Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 9 | 4 | 7 | 7 | |
Fabentech Fabentech is a privately owned biopharmaceutical SME based in Lyon (France) and created in 2009, which develops immunotherapies to address situations of emergency. In an environment where the globalization of trade accelerates the spread of epidemics and where the geopolitical context increases the risk of bioterrorist attacks, nations should be prepared to address various situations of public health & medical emergency. However, there is generally no real therapeutic option to fight acute symptoms arising from these neglected indications. Based on its horse F(ab’)2 platform, a fully-derisked technology in-licensed from Sanofi Pasteur, Fab’entech aims to provide therapeutic solutions in the fields … Tags: FrenchTech2030 Type: Startup Activities: biotech deeptech healthtech manufacturing Technologies: Synthetic Biology | 13 | 4 | 9 | 45 | |
Egualia – Industrie Farmaci Accessibili A better future. For everyone. Egualia (formerly Assogenerici) is the Italian Federation of Industries for Accessible Medicines which today represents more than fifty companies, over 95% of the companies producing generic, biosimilar and value-added medicines. Founded in 1993, it is a member of the European association of the sector, Medicines for Europe, and welcomes multinational and Italian companies present throughout the territory, which produce both for the domestic and foreign markets, as well as companies engaged in the production of drugs on behalf of third parties for the entire pharmaceutical industry. Generics and biosimilars cover 80% of therapeutic areas and … Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology | 7 | 0 | 7 | 18 | |
Value Edge Value Edge Research is a global business research, market intelligence, market research and sales analytics company providing support and outsourcing solutions to global bio-pharma companies. We are known for the high quality of our deliverables driven by a highly talented and experienced team from blue chip life science companies and life science solution providers. The firm's custom research and analytics and proprietary research reports and databases to global life science clients are highly cost effective. Value Edge is headquartered in India and the US office is located in the Greater Boston Area. For more information on Value Edge and its … Type: SMB Activities: biotech deeptech healthtech martech Technologies: Data Analytics | 16 | 2 | 6 | 22 | |
OPPI India Partnering India since pre-independence to improve patient safety & provide healthcare access to all. #BharatKeLiye The Organisation of Pharmaceutical Producers of India (OPPI) was established in 1965 and represents the research-based pharmaceutical companies in India. OPPI remains committed to supporting the nation’s healthcare objectives and collaborating with all stakeholders to find sustainable solutions. OPPI believes the need for innovation must be balanced with the necessity for more accessible medicines, within a robust IP environment. Vision: OPPI is an organisation of research and innovation driven pharmaceutical companies committed to addressing India's healthcare needs by: - Facilitating greater access to quality healthcare … Type: SMB Activities: healthtech biotech deeptech Technologies: Synthetic Biology | 8 | 1 | 8 | 15 | |
Merck India Merck is a leading science & technology company in the business of healthcare, life science & electronics. We are Merck, the vibrant science and technology company. Science is at the heart of everything we do. It drives the discoveries we make and the technologies we create. As a leading science and technology company, Merck operates across healthcare, life science and electronics. Our employees work to make a positive difference to millions of people’s lives every day by creating more joyful and sustainable ways to live. From advancing gene editing technologies and discovering unique ways to treat the most challenging diseases … Type: SMB Activities: deeptech biotech healthtech manufacturing nanotech Technologies: Semiconductors | 1 | 0 | 1 | 531 | |
Lab Unlimited Your single supplier for all laboratory instrumentation, consumables, training, service and validation needs! Lab Unlimited is part of the Carl Stuart Group. The Carl Stuart Group was founded in 1984 by Stuart and Gillian Smith. From a small beginning our business has grown to encompass many services and products, covering different market sectors and geographical regions. The focus of our business, however, remains the same. We are a customer orientated company and strive to meet and exceed your expectations in everything we do. As our portfolio grew we decided to present and promote our product and technical service offerings under … Type: SMB Activities: biotech deeptech manufacturing | 0 | 0 | 0 | 28 | |
The Pharmaceutical Managers Institute We strive to support our members ongoing learning, growth and professional development in a rapidly evolving industry. The PMI is a professional membership organisation dedicated to the continuous learning, development and support of those working in management within the pharmaceutical industry. Our membership is diverse, covering Commercial, Marketing, Market Access, Product Management and Regulatory roles; representating over 80 pharmaceutical organisations. The Institute has been built on 3 pillars, which are central to all the events and activities we run throughout the year. With our four different event series - Pharma Leaders, Pharma Managers, Women in Leadership and Masterclasses - we … Type: NGO, Think-tanks, Ed, & Culture Activities: biotech deeptech edtech | 22 | 0 | 22 | 10 | |
Healthxchange Group One of the most trusted and respected suppliers of pharmacy products to medical professionals. Healthxchange Pharmacy is the UK leading supplier of Botox® and other aesthetic products to medical professionals in the cosmetic sector across the UK and Europe, and we are the only authorised UK distributor for Obagi Medical Products, DR LEVY Switzerland, AQUALYX Fat Dissolving injectable and devices. Most of the top aesthetic and cosmetic physicians use Healthxchange Pharmacy for their clinical supplies because we deliver supplies quickly, accurately and at competitive prices, leaving them free to concentrate on the other aspects of their business. Ordering is easy: … Type: SMB Activities: healthtech | 0 | 0 | 0 | 101 | |
Excelya Expertly delivering clinical trials operations, with care. Excelya is an independent partner that serves Biotech, Pharma, and Medical Device organizations with a comprehensive range of Full-service CRO, FSP, and Resourcing solutions guided by compassion, care, and excellence. Founded in 2014 and headquartered in Paris, France, and operating in 28 countries across Europe, USA and India, Excelya has a global team of 900+ experts who understand the critical needs of clients to provide bespoke and robust trial solutions across a broad spectrum of therapeutic areas, with speciality focus on Oncology & Hematology, Rare Disease & Pediatrics, Infectious Disease, Inflammation & Immunotherapy, … Type: SMB Activities: healthtech biotech deeptech Technologies: Synthetic Biology | 8 | 2 | 3 | 702 |